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ABSTRACT
Gene expression analysis performed through com-
parative abundance of transcripts is facing a
new challenge with the increasing need to compare
samples of known cell number, such as early
embryos or laser microbiopsies, where the RNA
contents of identical cellular inputs can by nature
be variable. When working with scarce tissues, the
success of microarray profiling largely depends on
the efficiency of the amplification step as deter-
mined by its ability to preserve the relative abun-
dance of transcripts in the resulting amplified
sample. Maintaining this initial relative abundance
across samples is paramount to the generation
of physiologically relevant data when comparing
samples of different RNA content. The T7 RNA poly-
merase (T7-IVT) amplification is widely used for
microarray sample preparation. Characterization of
the reaction’s kinetics has clearly indicated that its
true linear phase is of short duration and is followed
by a nonlinear phase. This second phase leads to
modifications in transcript abundance that biases
comparison between samples of different types.
The impact assessment performed in this study
has shown that the standard amplification protocol
significantly lowers the quality of microarray data,
rendering more than half of differentially expressed
candidates undetected and distorting the true pro-
portional differences of all candidates analyzed.
INTRODUCTION
In the last decade, the emergence of high-throughput tech-
nologies has increased the rate of discoveries and expanded
our knowledge on molecular mechanisms and biological
processes. In the ﬁeld of transcriptomics, microarrays are
widely utilized for comparative RNA abundance studies
and have been shown to be a powerful tool for cellular
functions, metabolic pathways and pathologies studies.
One of the main limitations of microarrays is the
requirement for substantial RNA input to generate
hybridization samples. As a consequence, many research
applications with limited access to biological samples,
such as laser microdissection, early mammalian develop-
ment or single cell gene expression proﬁling, must rely on
an ampliﬁcation step to generate suﬃcient input material.
For this purpose, several methods have been proposed,
e.g. RiboSPIA (1), SMART PCR (2) or T7-IVT (3). The
T7-IVT approach is currently the preferred method due to
the linearity of its reaction kinetics. Reliability of this
method has been assessed to ensure the generation of
physiologically relevant microarray data. To date, the val-
idation of this ampliﬁcation method has been achieved by
evaluating its ability to maintain the relative abundance
between transcripts within a particular sample. By corre-
lating the relative proportions of candidates between the
unampliﬁed and ampliﬁed aliquots of a sample (4), it was
determined that this method introduces a slight bias in
overall transcript representation. Indeed, higher GC con-
tents and the presence of secondary structures found on
some mRNAs are assumed to lead to lower ampliﬁcation
rates which results in a bias in the relative proportions of
these gene transcripts relatively to the bulk of the messen-
gers that are ampliﬁed with more ease (5–7). Nonetheless,
the T7-IVT was deemed an appropriate global ampliﬁca-
tion method and has become well accepted, considering
that the potential for discovery exceeds the noise contri-
bution from these biases. Consequently, various techno-
logical platforms, including Aﬀymetrix, have implemented
the systematic use of this ampliﬁcation step in their stan-
dard procedures (8,9).
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ﬁxed amounts of RNA are compared and cell numbers
are accounted for through standardization using so-called
housekeeping candidates, which has since been proven
to be problematic as stable candidates across all treat-
ments or cellular states, let alone all tissues, have been
very diﬃcult to ﬁnd (10–14). As an alternative to house-
keeping genes, normalization to spiked controls is often
performed. This technique eﬃciently accounts for techni-
cal imprecision but does not take into consideration the
parameters of the initial samples, including cell counts. In
other words, in a situation of ﬁxed RNA input, diﬀerences
observed in transcript abundance become physiologically
relevant only with the assumption that the cells from these
samples share a similar level of overall gene expression,
hence of RNA content. However, many cellular states are
known for their atypical transcriptional activity. For
instance, senescent cells, such as germ cells or stem cells,
are known to be more quiescent, whereas actively dividing
cancer cells are metabolically hyperactivated (15) and thus
exhibit high transcription levels. These diﬀerences in tran-
scription activity between samples of diﬀerent cell type
and/or status carry highly valuable information that
could aﬀect data analysis. The ability to preserve these
diﬀerences is invaluable for comparative microarray stra-
tegies. Samples of ﬁxed cell number oﬀer a novel perspec-
tive by enabling the comparison of transcript abundance
across samples of diﬀerent type. Consequently, following
the development of techniques for the isolation of individ-
ual cells from complex tissues, comparative studies with
samples of ﬁxed cell number have become increasingly
common. The comparison of samples of known cell
number dictates that in addition to the proportional rep-
resentation of mRNA between ampliﬁed and unampliﬁed
aliquots of the same sample, an additional proportional
representation must be preserved throughout the micro-
array sample preparation procedure. As such, the ampli-
ﬁcation step is required to preserve two types of
proportions: (i) the aforementioned relative abundance
between transcripts within samples, and (ii) the propor-
tional diﬀerences in total RNA contents naturally occur-
ring between samples of diﬀerent type. Figure 1 illustrates
the two types of proportional distortions where the
sequence related bias is illustrated by lanes A–C, whereas
the proportional representation between samples is found
in lanes D–F. To date, ampliﬁcation methods have not
been tested for their ability to maintain the latter type of
proportion.
Here, we tested the ability of T7-IVT ampliﬁcation to
maintain this relative global abundance diﬀerences across
samples of diﬀerent RNA contents. The comparisons were
performed using bovine oocytes and early embryos. It is
known that in the cow, the ﬁrst cell cycles occur in the
absence of transcription (16,17). During this period of
transcriptional silence, protein production is sustained
through the use of the mRNAs stored during oogenesis.
These maternal RNA pools are gradually depleted until
embryonic genome activation (EGA), which in the cow
occurs at the 8- to 16-cell stage (17). Therefore, prior to
EGA, the number of nuclei is irrelevant as the RNA con-
tent across development represents the fraction of RNA
remaining from the original oocyte pools. Consequently,
to characterize the making of an early embryo prior to the
EGA, it is the RNA content of the whole embryo that
is compared and considered as the experimental unit.
The comparisons performed herein accounted for the
two extremes in RNA contents, i.e. the rich state that
is the fully grown germinal stage oocyte to the lower-
abundance state represented by the early 8-cell embryo.
The linearity of the T7-IVT was characterized and,
according to the kinetics observed, a procedure to follow
antisense (aRNA) production in real time was developed.
The global ampliﬁcation method was tested to generate
samples suited for microarray hybridization by comparing
the RNA content of these developmental samples under
the standard conditions and following a modiﬁed ampliﬁ-
cation procedure. Validation of the proportional RNA
abundance diﬀerences was done using real-time PCR.
The results clearly indicate that the modiﬁed procedure
generates physiologically relevant RNA abundance data,
whereas the recommended protocol introduces an impor-
tant skew in the relative abundance values.
MATERIALS AND METHODS
All chemicals were obtained from Sigma–Aldrich
(St. Louis, MO, USA) unless otherwise stated.
Oocyte recovery and selection
For germinal vesicle (GV) stage oocyte samples, bovine
ovaries were collected at a commercial slaughterhouse
and transported to the laboratory in a 0.9% NaCl aque-
ous solution containing an anti-mycotic agent. Cumulus–
oocyte complexes (COCs) from 3- to 6-mm follicles were
Figure 1. Schematic representation of the two potential biases that need
to be considered when using an ampliﬁcation step to produce relevant
microarray data. Open circles represent individual expressed sequence
tags (ESTs) that are distributed according to their relative proportions
(higher position meaning more abundant). Columns A–C represent the
intrasample bias where A: the original unampliﬁed distribution; B: the
ampliﬁed output with original proportions kept; and C: is the ampliﬁed
output that harbors skews in the relative representations between ESTs.
Columns D–F represent the intersample bias where D: relative distri-
butions of the two original samples; E: ampliﬁed outputs with kept
proportions between samples; and F: ampliﬁed outputs with skewed
relative proportions between the samples but intact relative proportions
within samples.
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10-ml syringe. Healthy COCs with at least ﬁve layers of
cumulus were selected to proceed. The cumulus cells were
removed mechanically by vortexing. The denuded oocytes
were placed in PBS and washed generously, at least three
times, to ensure the absence of contamination by cumulus
cells. Pools of 10 GV oocytes collected on diﬀerent days
were then frozen in a minimal volume of PBS and stored
at –808C until RNA extraction.
In Vitro production of 8-cell embryos
For in vitro maturation, COCs bearing the characteristics
described above underwent in vitro maturation after three
washes in HEPES-buﬀered Tyrode lactate medium (TLH)
supplemented with 5% bovine serum, 0.2mM pyruvic
acid and 50mg/ml gentamicin. Groups of 10 COCs were
placed in droplets of media under mineral oil. Each drop-
let consisted of 50ml of maturation medium composed of
modiﬁed synthetic oviductal ﬂuid (SOF) medium (18,19)
with 5% decomplemented fetal calf serum (Hyclone,
Ottawa, ON, Canada), 1X modiﬁed Eagle’s medium
(MEM) nonessential amino acids (Gibco BRL,
Burlington, ON, Canada), 1X MEM essential amino
acids (Gibco BRL), as well as 1mM glutamine supplemen-
tedwith0.1mg/mlrecombinantFSHand1mg/ml17b-estra-
diol. The droplets containing COCs were incubated in a
humidiﬁed atmosphere for 24h at 38.58C with 5% CO2.
In vitro fertilization of matured COCs were added to
48-ml droplets under mineral oil. The droplets were com-
posed of modiﬁed TLH supplemented with 0.6% BSA
fatty-acid free (Lifeblood Medical, Adelphia, NJ, USA),
0.2mM pyruvic acid, 10mg/ml heparin and 50mg/ml gen-
tamicin. Prior to transfer, the COCs were washed twice in
TLH medium. Once transferred, 2ml of PHE (1mM hypo-
taurine, 2mM penicillamine, 250mM epinephrine) were
added to each droplet  10min before semen was added.
The semen used consisted of a cryopreserved mixture
of ejaculates from ﬁve bulls (Centre d’Inse ´ mination
Artiﬁcielle du Que ´ bec, St.-Hyacinthe, QC, Canada). The
semen was thawed in 378C water for 1min, put on a dis-
continuous Percoll gradient (2ml of 45% Percoll over 2ml
of 90% Percoll) and centrifuged at 700g for 30min at
268C. The pellet was resuspended in 1ml of modiﬁed
Tyrode medium and centrifuged at 250g for 5min at
268C. The supernatant was discarded, an aliquot was
used to determine the spermatozoa content using a hemo-
cytometer, and the remaining fraction was resuspended
in IVF medium to obtain a ﬁnal concentration of 25 
10
6cells/ml. Finally, 2ml of the sperm suspension were
added to each droplet and incubated in a humidiﬁed
atmosphere at 38.58Ci n5 %C O 2 for 15–18h.
Following fertilization, putative zygotes were mechani-
cally denuded by repeated pipetting, washed three times
in SOF1 with 5% decomplemented fetal calf serum for
complete removal of cumulus cells from solution and
transferred to culture droplets (50ml) in groups of 20–30
embryos. Embryo culture was performed in SOF1 under
mineral oil at 38.58Ci n5 %C O 2 in a reduced oxygen
atmosphere (7%) with high humidity. SOF1 medium
was replaced after 72h by SOF2 to prevent toxicity due
to ammonium accumulation resulting from amino acid
degradation. The SOF1 medium contained 5% decomple-
mented fetal calf serum, 1  MEM nonessential amino
acids, 1mM glutamine, 1.5mM glucose and 10mM
EDTA. The SOF2 medium contained 5% decomplemen-
ted fetal calf serum, MEM nonessential amino acids,
MEM essential amino acids, 1mM glutamine and
1.5mM glucose. The 8-cell embryos were collected 72h
postfertilization, washed three times in PBS, collected in
groups of 10 in small volumes of PBS, frozen and stored
at –808C until RNA extraction.
RNA extraction and standard global mRNA amplification
Total RNA from oocytes and 8-cell embryos was
extracted using the PicoPure RNA isolation Kit
(Molecular Devices, Sunnyvale, CA, USA) following the
manufacturer’s protocol and including DNase I treatment
to remove genomic DNA. Total RNA integrity and con-
centration were evaluated using the 2100-Bioanalyzer
(Agilent Technologies, Palo Alto, CA, USA) with the
RNA PicoLab Chip (Agilent Technologies).
The global mRNA ampliﬁcations by T7-IVT were
performed using the RiboAmp HS RNA Ampliﬁcation
Kit (Molecular Devices) according to the manufacturer’s
instructions. In the standard ampliﬁcation procedure, two
ampliﬁcation rounds of 6h each were performed. The
aRNA output was quantiﬁed using the NanoDrop ND-
1000 (NanoDrop Technologies, Wilmington, DE, USA).
Determination of first-round amplification kinetics
Total RNA of a pool of 10 GV oocytes and one of 10
eight-cell embryos was extracted as described above, and
both samples were subjected to the ﬁrst ampliﬁcation
round following the manufacturer’s instructions. During
the IVT incubation, a 1ml aliquot was removed after
0, 10, 20, 30, 40, 50, 60, 120, 180, 240, 300 and 360min.
The 12 aliquots were then reverse transcribed using the
Sensiscript Reverse Transcriptase (Qiagen, Mississauga,
ON, Canada) according to the manufacturer’s instruc-
tions, except that 2.5mM of random decamers
RetroScript (Applied Biosystems/Ambion, Austin, TX,
USA) were used instead of an oligo-dT. Real-time PCR
(as described below) was performed on each GV oocyte
and 8-cell embryo cDNA aliquot using primers targeting
a high-abundance gene [actin, gamma 1 (ACTG1)] and
a low-abundance candidate [High-mobility group box 1
(HmgB1)].
Determination of second-round amplification kinetics
Total RNA of pools of 10 GV oocytes and 10 eight-cell
embryos were ampliﬁed by two rounds of ampliﬁcation
with a minor modiﬁcation. During the second round,
30mCi of alpha-
32P UTP (GE Healthcare, Baie d’Urfe ´ ,
QC, Canada) was added to the IVT reaction. Two-micro-
liter aliquots were collected after 0, 15, 30, 45, 60, 120, 240
and 360min of reaction. The eight aliquots were cleaned
using the PicoPure RNA isolation Kit (Molecular
Devices) and eluted in an 11ml volume. A 5-ml aliquot
of each aRNA eluate was combined with 10ml of scintil-
lation liquid (Budget solve scintillation cocktail, VWR,
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were measured using a liquid scintillation counter
(Tri-Carb 2100TR, PerkinElmer BioSignal, Inc.,
Montreal, QC, Canada).
Broken beacon design and validation
The broken beacon is composed of two oligonucleotides
(Figure 2) and is designed to target the aRNA coding for
the bovine actin, beta (ACTB) gene. The oligonucleotide
bearing the complementary sequence to the ACTB aRNA
contains a ﬂuorophore (ﬂuo-oligo), whereas the second
oligonucleotide contains a quencher (quencher-oligo).
The choice of ﬂuorophore was determined according to
its suitability with the LightCycler 1.5 instrument
(Roche Diagnostics, Laval, QC, Canada). Consequently,
the ﬂuo-oligo was synthesized with the 6-FAM on its 50
extremity (Integrated DNA Technologies, Coralville, IA,
USA) while the quencher-oligo was conjugated on its 30
end with the Dabcyl dark quencher (Integrated DNA
Technologies). Since it was observed that, with shorter
excitation wavelength ﬂuorophores such as FAM, the
adjacent nucleotide can have a strong quenching impact,
the design was restricted so the nucleotide adjacent to
the ﬂuorophore was a thymidine, which has the lowest
quenching capacity (20). Selected sequences for the
broken beacon, i.e. the sequences of the ﬂuo-oligo, the
quencher-oligo and an antisense single-strand DNA
(ssDNA) control, are listed in Supplementary Data
Table 1.
The ratio of ﬂuo-oligo to quencher-oligo was set at 1:2,
as this proportion was previously established to be opti-
mal for minimizing background ﬂuorescence (21,22).
In order to evaluate the eﬃciency of the broken beacon
to detect the target sequence, various amounts of the
ssDNA target control were spiked into a solution mimick-
ing the incubation conditions of the T7-IVT at the tem-
perature used for the global mRNA ampliﬁcation (428C).
A standard curve using the spiked ssDNA antisense
ACTB was performed and ﬂuorescence was monitored
using the LightCycler. Each target concentration for the
standard curve contained 20mM of ﬂuo-oligo and 40mM
of quencher-oligo. At this concentration, the ﬂuo-oligo
and the quencher-oligo were prehybridized together at
room temperature at least 10min in the dark prior to
use. Antisense ssDNA target concentrations of 0, 50,
100, 200, 300, 400, 500, 600, 800 and 1000nM were
tested. The prehybridized ﬂuo-quencher oligos were
added to each of the samples spiked with the antisense
ssDNA target in the IVT reaction solution (Molecular
Devices) in a ﬁnal volume of 20ml. Due to the requirement
of the T7 RNA polymerase for Mg
2+ ions, all IVT sam-
ples were put into plastic capillaries (Roche Diagnostics).
The size proﬁle of the aRNA products of both rounds was
determined using an aliquot of the end products that were
run onto a microﬂuidic Chip read on a 2100-BioAnalyzer
system (Agilent).
Real-time monitoring of aRNA production with the
broken beacon
Real-time monitoring of aRNA production during the
ﬁrst and second T7-IVT incubations was performed
using the broken beacon. For both T7-IVT rounds, the
preparation and concentration of each oligo were as
described above. All T7-IVT reactions were performed
in plastic capillaries (Roche Diagnostics) and incubated
at 428C in a LightCycler apparatus (Roche Diagnostics)
where the ﬂuorescence was measured every 5min in the
F1 channel.
Figure 2. Schematic representation of the broken beacon. The ﬂuorescent oligonucleotide (ﬂuo-oligo) forms a duplex with the quencher oligonucleo-
tide (quencher-oligo); the proximity of the ﬂuorophore and the quencher prevents ﬂuorescence emission. In the presence of the target sequence, the
quencher-oligo is displaced, allowing the ﬂuo-oligo to emit.
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of the impact of the T7-IVT duration
The total RNA of pools of 10 GV oocytes or 8-cell
embryos was isolated as described above. Six samples
for each developmental stage were extracted. Keeping
each developmental stage separated, eluates containing
the total RNA samples were pooled together in order to
attenuate the biological and technical variations between
pools, thus highlighting only the impact of the intrinsic
diﬀerence in starting material between developmental
stages. One-sixth of each pool was subjected to the
T7-IVT ampliﬁcation. The duration of the T7-IVT incu-
bation was determined either to be 6h as the standard
protocol recommends or restricted according to the real-
time monitoring of the reactions’ kinetics, the incubations
being stopped when one of the samples started showing
signs of reduction in aRNA production (roughly 40 and
50min for the ﬁrst and second rounds, respectively). The
aRNA output was monitored in real-time for all samples.
For the microarray hybridizations, a dual-color design
using a common reference was used. An RNA reference
made by T7-IVT from a pool of oocytes and early
embryos was labeled and hybridized on all microarrays
to account for hybridization and scanning imprecision.
Following the ampliﬁcation reaction, the aRNA content
was quantiﬁed using the NanoDrop ND-1000 (NanoDrop
Technologies).
Sample labeling and microarray hybridization
To avoid biases induced by lower signal intensities,
which are generated by less-concentrated samples, a
ﬁxed amount of aRNA (2mg for developmental samples
and 2.5mg for the common reference) was hybridized to
each microarray. To account for the initial proportional
diﬀerences in sample concentration, a synthetic GFP
RNA (23) was spiked in prior to labeling and sampling.
The GFP intensity values were latter used to correct the
overall intensity values for each of the biological samples.
All developmental aRNA samples were spiked with 100ng
of GFP RNA. The labeled aRNA samples spiked with the
GFP control and the reference were pooled and puriﬁed
using the Picopure RNA extraction kit (Molecular
Devices) and resuspended in 12ml of elution buﬀer
before hybridization. Microarray samples (including the
aRNA common reference) were labeled indirectly using
DY647-ULS for the oocyte/embryo and DY547-ULS
for the reference from the ULS aRNA Fluorescent
Labelling kit (Kreatec Biotechnology, Amsterdam, The
Netherlands) according to the manufacturer’s protocol.
The labeling eﬃciency was measured using the
NanoDrop ND-1000 (NanoDrop Technologies).
All 12 hybridizations were performed using our custom
bovine developmental cDNA microarray (v.1.3) contain-
ing 2441 ESTs derived from subtracted libraries (this EST
collection represents 1540 Unigenes) (24). Hybridizations
were performed in Slidehyb buﬀer #1 (Ambion,
Austin, TX, USA) at 508C for 18h in the SlideBooster
hybridization station (Advalytix, San Francisco, CA,
USA). Slides were then washed twice with 2  SSC-0.5%
SDS at 508C for 15min and twice with 0.5  SSC-0.5%
SDS at 508C for 15min. The slides were dipped three
times in 1  SSC and three times in H2O. Finally, the
slides were dried by centrifugation at room temperature
at 1200g for 5min.
The slides were scanned using the VersArray
ChipReader System (Bio-Rad, Mississauga, ON,
Canada) and visualized with the ChipReader software
(Media Cybernetics, San Diego, CA, USA). Microarray
image processing was performed with the ArrayPro
Analyzer software (Media Cybernetics).
Microarray data analysis
A three-step strategy was used to normalize our micro-
array data. First, in order to remove any spatial eﬀect
on the array, an ANOVA analysis was performed on
each array, by computing and subtracting any column
eﬀect (four columns of subarrays on each array), any
row eﬀect (considering only two rows of subarrays, i.e.
the top 16 and the bottom 16 subarrays since they are
identical replicates) and any column/row interaction.
Then, in order to account for hybridization eﬃciency to
normalize data between arrays and account for the array
eﬀect, an ANOVA analysis was performed on all the
arrays using only the reference samples. An array eﬀect
was then estimated and removed from the expression of
both the reference and the developmental stage expres-
sions. Finally, since all microarray samples were prepared
from a ﬁxed amount of aRNA (2mg) to avoid any bias
introduced by the preponderance of low signal intensities
in the less abundant samples, it was essential to use a
spiked-in control to normalize and restore the natural
divergences found in the initial sample concentrations.
As such, the spiked-in GFP control, whose signal is
proportional to the volume that was taken from each
sample to get 2mg of aRNA, was normalized to be con-
stant across the diﬀerent cell stages, which consequently
transformed the datasets to account for the natural diﬀer-
ences in RNA content that characterize the bovine early
developmental stages. The normalized data was then
uploaded to the NIA Array Analysis tool for analysis
(25). First, background threshold was determined accord-
ing to the plot of error function [SD (= square root of the
error variance) versus expression level (log intensity)].
Clones with a mean log signal intensity above the
calculated background threshold (log 2) were
considered present. Next, a one factor one-way ANOVA
(default parameters, except FDR < 0.05) was performed.
Further data processing including correlation coeﬃcient
for technical replicates, hierarchical clustering and mean
pair-wise comparison between the two biological samples
were also performed using the NIA microarray analysis
tool (http://lgsun.grc.nia.nih.gov/ANOVA/). The dataset
is available on the ArrayExpress website (www.ebi.ac.
uk/microarray/as/ae/).
Reverse transcription of nonamplified RNA and aRNA
from oocytes and 8-cell embryos
Estimation of the impact of the duration of the T7-IVT
incubation and validation of the microarray data were
performed using real-time PCR measuring transcript
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sample types were compared: (i) non-ampliﬁed, (ii) stan-
dard ampliﬁcation (e.g. two rounds of 6h) and (iii)
restricted ampliﬁcation using real-time monitoring of
aRNA production. In the nonampliﬁed group, total
RNA of three pools of 10 oocytes and three pools of 10
eight-cell embryos were reversed transcribed using the
Sensiscript Reverse Transcriptase (Qiagen) according to
the manufacturer’s instructions. With the samples from
the standard and restricted T7-IVT, 1ml of aRNA was
diluted in 50ml of RNase-free water (Sigma), and 1ml
of this dilution was reversed transcribed using the
Transcriptor Reverse Transcriptase (Roche Diagnostics)
following the manufacturer’s protocol, except that
50mM of random decamers RetroScript (Applied
Biosystems/Ambion) and 1mM of oligo-dT were used in
the reaction. This switch in reverse transcriptase enzyme
was necessary as the aRNA samples are too concentrated
for the SensiScript whereas unampliﬁed samples are too
diluted for the Transcriptor.
Real-time PCR
The primers for each candidate were designed using the
Primer3 web interface (http://frodo.wi.mit.edu/cgi-bin/
primer3/primer3_www.cgi). Sequences, size of ampliﬁed
product, GenBank accession numbers as well as annealing
temperatures are presented in Supplementary Data
Table 2. For each target ESTs tested, a standard curve,
consisting of PCR products puriﬁed with the QIAquick
PCR Puriﬁcation Kit (Qiagen) and quantiﬁed with a
spectrophotometer (NanoDrop ND-1000, NanoDrop
Technologies), was included in the run. The standard
curve consisted of ﬁve standards of the puriﬁed PCR
products diluted from 0.10pg to 0.1fg. Real-time PCR
was performed on a LightCycler apparatus (Roche
Diagnostics) using SYBR green incorporation for real-
time monitoring of amplicon production. The reaction
was performed in glass capillaries (Roche Diagnostics) in
a ﬁnal volume of 20ml.
For the determination of ﬁrst-round ampliﬁcation
kinetics, 1.5-ml aliquots of each oocyte and 8-cell cDNA
sample were used per PCR reaction. For transcript abun-
dance measurement in the nonampliﬁed, ampliﬁed 6h and
restricted ampliﬁcation samples, 1ml of cDNA was used.
In addition to cDNA template, the reaction mixture con-
sisted of 0.25mM of each primer, 3mM of MgCl2 in
1  SYBR green mix containing dNTPs, FastStart DNA
polymerase enzyme, and buﬀer (Roche Diagnostics). The
PCR conditions used for all candidates were as follows:
denaturation cycle of 10min at 958C; 45 PCR cycles (dena-
turation: 958C for 5s; annealing: speciﬁc temperature, see
Supplementary data Table 2, for 5s; extension: 728C for
20s); followed by a melting cycle. The DNA quantiﬁcation
was performed using LightCycler Software Version 3.5
with reference to the standard curve. The real-time PCR
productspeciﬁcitywasconﬁrmedbyanalysisofthemelting
curve given by the LightCycler software. The products
were then electrophoresed on a 1.5% agarose gel and
sequenced to conﬁrm the identity of the ampliﬁed product.
DNA sequencing and clone identification
DNA sequencing and clone identiﬁcation were performed
as previously described (26). Brieﬂy, the resulting sequence
traces were visualized with the online freeware Chromas
1.45 (http://www.technelysium.com.au/chromas.html)
and uploaded to a cDNA Library Manager program
(coded by Genome Canada Bioinformatics) that auto-
mates sequence analysis and clone identiﬁcation (27).
For clone identiﬁcation, sequence traces were uploaded
to the cDNA Library Manager, trimmed (Phred software)
and compared against a locally installed GenBank data-
base (Basic Local Alignment Search Tool (BLAST);
http://www.ncbi.nlm.nih.gov/blast/).
RESULTS
Assessing the kinetics of the T7-IVT amplification reaction
Characterization of the kinetics of aRNA production for
both ampliﬁcation rounds was done using bovine GV
oocytes and 8-cell embryos. These tissues were chosen as
representative samples for their two very diﬀerent intrinsic
RNA contents. Monitoring of the ﬁrst ampliﬁcation
round was performed by real-time PCR. Aliquots were
taken at diﬀerent time points during IVT incubation and
reverse transcribed before a real-time PCR was performed
using ACTG1, a highly abundant mRNA, and HMGB1, a
low-abundance transcript. The relative transcript abun-
dance was plotted as a function of the incubation time.
As shown in Figure 3A, the kinetics of aRNA production
was linear for the ﬁrst 40min. Then the slope dramatically
changed and aRNA production slowly and gradually
reached a stationary-like phase. This phenomenon was
observed irrespectively of the sample or candidate gene
studied.
To study the kinetics of the second ampliﬁcation round,
a diﬀerent methodological approach was required since
aRNA fragments were then much smaller (Figure 4) due
to the necessary use of random primers to initiate reverse
transcription. This shorter product size prevented proper
real-time PCR ampliﬁcation (data not shown), most prob-
ably because this high fragmentation also occurs between
both priming sites and results in fragments bearing only
one primer sequence, thus preventing exponential
ampliﬁcation.
We thus used radiolabeled UTP incorporation to follow
aRNA production during the second IVT round. The
CPMs were plotted as a function of reaction time
(Figure 3B). For both sample types, the second ampliﬁca-
tion round was truly linear during the ﬁrst 50min, then the
incorporation rate began to slowly decline. These aRNA
production proﬁles indicated that the true linear phases
of both T7-IVT rounds are relatively short.
Broken beacon design and validation
The design of the broken beacon was inspired by Blair
and colleagues (22), who used this type of probe to mon-
itor RNA polymerase activity. As shown in Figure 2, the
broken beacon consists of two complementary oligonu-
cleotide probes of diﬀerent lengths. The longer sense
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oligo) and the shorter antisense probe harbours a non-
ﬂuorescent quencher on its 30 end (quencher-oligo).
When hybridized together, the complex is nonﬂuorescent
due to the proximity of the ﬂuorophore to the quencher.
In the presence of the aRNA target, the ﬂuorescent sense
probe forms a more stable duplex with the target and
displaces the quencher strand, allowing the ﬂuorophore
of the sense probe to emit. The designed broken beacon
speciﬁcally targets the bovine ACTB sequence.
The potential of the broken beacon to form a duplex
with its target sequence under the T7-IVT reaction con-
ditions (especially at the low temperature and high Mg
2+
concentration used), as well as its ability to do so quanti-
tatively, was investigated by using various amounts of a
speciﬁc antisense ssDNA template that was added to the
T7-IVT reaction master mix without the RNA polymer-
ase. The calculated ﬂuorescence intensity was plotted as
a function of DNA target concentration (Figure 5).
The ﬂuorescence concentration curve indicates that
the broken beacon can eﬃciently hybridize with the
ssDNA target and its ﬂuorescence is proportional to the
target concentration. Moreover, when the broken beacon
was incubated without template, the emitted ﬂuorescence
was weak and near the background threshold.
Monitoring aRNA production in real time
The two ampliﬁcation rounds of the T7-IVT reaction
were monitored in real time with the broken beacon.
In Figure 6A, the ampliﬁcation reaction lasted 6h, in
accordance with the manufacturer’s protocol. As observed
previously (Figure 3) for the ﬁrst round, the reduction in
aRNA production was initiated only after a 40-min incu-
bation, while it was initiated after 50min for the second
round. This kinetics was observed for both sample types.
This T7-IVT ampliﬁcation was repeated with aliquots of
the same samples from either oocytes or 8-cell embryos,
but this time the reaction was stopped during the linear
phase (Figure 6B), as determined by a change in the slope
of the ﬂuorescence proﬁles. The aRNA yields obtained
after these standard or restricted ampliﬁcations are listed
in Table 1. The aRNA yields for the 8-cell samples follow-
ing the ﬁrst round in the restricted context were lower
than the absorbance detection limit of the spectrometer,
Figure 3. Characterization of the kinetics of each T7-IVT ampliﬁcation round. Two tissues were tested, i.e. germinal-stage oocytes and 8-cell
embryos. (A) The aRNA production during the ﬁrst round was followed using real-time PCR targeting the actin gamma 1 (ACTG1) and high-
mobility group box 1 (HmgB1) transcripts. (B) The aRNA production during the second round was followed by measuring the incorporation of
radiolabeled UTP.
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samples. Overall, the aRNA output from restricted incu-
bations were much lower than the ones obtained following
the standard 6-h incubation protocol. In the full 6-h incu-
bation protocol, a diﬀerence of about 3.3-fold between
oocyte and 8-cell samples was observed following the
ﬁrst round, whereas little diﬀerence was observed follow-
ing the second round. By contrast, in the restricted sam-
ples, the proportional diﬀerence in aRNA output
following the second round between the two tissue types
was about 4.5-fold. This lack of proportional output dif-
ference across tissues when performing the full 6-h incu-
bation clearly indicates the introduction of an intersample
methodological bias. To study the extent of the impact
of this skew, a microarray-based comparative approach
was used.
Microarray data normalization
In addition to the duration of the ampliﬁcation procedure,
the relative RNA contents will be aﬀected by microarray
data normalization. The choice of an appropriate
data normalization method is paramount for subsequent
analysis and will vary depending on the tissues or cells
studied. In the context of samples with considerable dif-
ferences in RNA content and overall RNA abundance
that might be signiﬁcantly diﬀerent, the largely used
Lowess (or Loess) normalization for dual-labeled micro-
arrays is inappropriate. The main assumption of the
Lowess normalization method is that most genes are
not diﬀerentially expressed between studied samples (28).
This assumption clearly does not match the present con-
text of oocytes and 8-cell embryos. The normalization
must then rely on spikes and exogenous standards.
Herein, the microarray samples were prepared from a
ﬁxed amount of aRNA (2mg) to avoid introducing a
bias originating from the low signal intensities that
would be more prevalent in the low-abundance tissue.
Indeed, comparison of signal intensities generated from
hybridization samples prepared using diﬀerent aRNA
input would suﬀer from the increased variance found in
the low-intensity signals. In order to account for the initial
diﬀerences in RNA contents between sample types, a nor-
malization strategy based on the concentration of the sam-
ples in aRNA was utilized. Since the concentration of
aRNA varies between samples, the volume taken from
each sample to obtain 2mg of aRNA diﬀered proportion-
ally. In order to take into account such a diﬀerence, an
equal amount of an in vitro produced RNA coding for the
GFP protein was spiked into every sample following
ampliﬁcation. The signal strength generated by the GFP
spike was therefore representative of the volume taken,
and thus of aRNA abundance, and was used to normalize
the microarray data. This method maintains the diﬀer-
ences in relative abundance between these two develop-
mental stages.
Microarray profile of standard and restricted
amplifications
The RNA abundance data analysis of oocytes and 8-cell
embryos from standard and restricted ampliﬁcations
was performed with the NIA Array Analysis tool, and
candidates with mean log signal intensities above the estab-
lished cutoﬀ value threshold (log-intensity 2) were consid-
ered to be expressed, whereas candidates with signal
intensities below the threshold were designated as absent.
A pair-wise comparison of means for RNA abundance
was done with the oocyte and 8-cell embryo data sets.
To increase the level of conﬁdence, a combination of
both false discovery rate control (FDR) of 0.05 and fold
change criteria of 2 were used to identify the over- and
underexpressed. Such stringent sorting was used to
Figure 4. Total RNA micro-electrophoretic proﬁles of ﬁrst-round
and second-round T7-IVT aRNA outputs. S=seconds and FU=
Fluorescent units. M=spiked in marker.
Figure 5. Standard curve of ﬂuorescence emitted by the broken
beacon versus concentration of the single-stranded antisense actin
beta (ACTB) target.
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of the ampliﬁcation strategies. As shown in Figure 7A,
a total of 688 and 1175 ESTs were found to be more
abundant in the oocyte compared to the 8-cell embryo
with hybridization samples prepared from the standard
6-h protocol and the restricted protocol, respectively.
Among these, 572 ESTs were common to both lists,
whereas 116 were found only in the 6-h list and 603
were speciﬁcally identiﬁed with the restricted protocol.
In contrast, the majority of the underexpressed candi-
dates, that is 71, were mostly common for both protocols,
whereas only nine candidates were found only with the
standard incubation and 13 with the restricted protocol
(Figure 7B).
Comparative RNA abundance of candidates by
real-time PCR
To validate the microarray results and to assess the extent
of the relative distortion, the abundance in RNA content
Figure 6. (A and B) Fluorescence history charts of real-time monitoring of the ampliﬁcation reaction using the broken beacon. Both rounds were
monitored in both sample types, i.e. GV oocytes and 8-cell embryos.
Table 1. Total aRNA yield for the ﬁrst and second rounds of the IVT reaction for the standard (6h) and restricted (X h) ampliﬁcation for both
the GV oocyte and 8-cell embryo samples
Samples First-round
ﬁnal aRNA yield
(mg) after 6h
Second-round
ﬁnal aRNA yield
(mg) after 6h
First-round ﬁnal
aRNA yield (mg)
after X h
Second-round
aRNA yield (mg)
after X h
Oocytes_pool 1 0.71 59.03 0.21 20.44
Oocytes_pool 2 0.78 61.58 0.18 15.36
Oocytes_pool 3 0.85 60.03 0.21 18.12
8-cell_pool 1 0.20 49.32 NA 4.39
8-cell_pool 2 0.23 52.04 NA 4.66
8-cell_pool 3 0.27 49.12 NA 4.48
NA, not applicable: the aRNA concentration measured was below the spectrophotometer detection limit.
Figure 7. Venn diagrams highlighting the proportional overlaps and
divergences in gene lists of ESTs with signiﬁcant abundance diﬀerence
between both ampliﬁcation protocols [standard (6h) versus restricted
(X h)]. In both cases, the candidates selected were those that were more
prevalent in (A) the GV oocyte or (B) the 8-cell embryo.
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For both tissues, i.e. GV oocytes and 8-cell embryos, the
abundance in mRNA of speciﬁc candidates was measured
from the outputs of the two ampliﬁcation protocols
and proportionally compared to unampliﬁed samples
(Figure 8). As a basis for comparison, the mean relative
abundance found in the oocyte samples was set at 100%
for every condition. This allowed for the comparison
of the relative proportion between the oocyte and the
8-cell embryo for both of the ampliﬁcation procedures.
These proportions can also be compared to the unampli-
ﬁed samples considered as the gold standard bearing the
Figure 8. Relative abundance of candidate gene transcripts in unampliﬁed or ampliﬁed samples following the restricted ampliﬁcation protocol
(identiﬁed on the charts by ‘xh’) or following the standard procedures (two rounds of 6h) identiﬁed by ‘6h’. For each group, the mean abundance
value of the GV oocyte was set as standard relative basis. CCNB1, cyclin B1; DDX5, DEAD box polypeptie 5; DENR, density-regulated protein;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; KLF10, Kruppel-like factor 10; LDHB, lactate dehydrogenase B; NLRP9, NLR family, pyrin
domain containing 9; OLFML1, olfactomedin-like 1; PABPC1, poly(A)-binding protein cytoplasmic 1; PTTG1, pituitary tumor-transforming 1;
SNW1, SNW domain containing 1; SVIL, supervillin.
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stages.
For all candidates, a distorted proportion was found for
the samples prepared using the standard 6-h protocol
when compared to the proportion of the unampliﬁed
sample used as reference. The skew was clearly caused
by an over-ampliﬁcation of the 8-cell samples. In some
cases, such as the ones presented for cyclin B1
(CCNB1), lactate dehydrogenase B (LDHB), olfactome-
din-like 1 (OLFML1) and poly(A)-binding protein cyto-
plasmic 1 (PABPC1), conclusions drawn from the relative
RNA abundance measurements using the samples ampli-
ﬁed under standard conditions would be erroneous.
By contrast, the relative abundances from the restricted
ampliﬁcation were highly similar to the unampliﬁed con-
trol (Figure 8).
DISCUSSION
When working with scarce tissues, the success of global
RNA abundance proﬁling using microarrays largely
depends on the eﬃciency of the ampliﬁcation step to pre-
serve the relative abundance of transcripts in the resulting
ampliﬁed sample. Concerns over sequence-speciﬁc altera-
tions in the ampliﬁcation kinetics that would result in the
introduction of a skew in the relative abundance between
candidate gene mRNAs within sample (Figure 1, columns
A–C) have been addressed previously (5–7,29). The aim of
the present study was rather to determine the presence of a
diﬀerent type of distortion that could impact the relative
RNA contents across samples of diﬀerent total contents
(as represented in Figure 1, columns D–F). This is of par-
ticularly high relevance when considering the fact that
cell types or cells under diﬀerent physiological states can
exhibit major variations in their overall gene expression
activity. Such a situation is becoming more prevalent with
our growing ability to compare samples of known cell
contents, including single-cell transcriptome proﬁling.
Our initial premise that the ampliﬁcation step was intro-
ducing an important bias came from observations using
early mammalian embryos, in which we observed that
aRNA outputs were similar regardless of the embryonic
stage and did not reﬂect the physiology of the developing
embryo. In the present study, characterization of the
kinetics of aRNA production, followed using diﬀerent
approaches, highlighted a production that quickly
slowed to gradually reach a plateau-like phase (Figures 3
and 6). These observations conﬁrm the presence of a non-
linear ampliﬁcation phase that introduces a skew in the
ampliﬁed end products by homogenizing the outputs and
therefore eliminating the initial relative proportions in
RNA contents. The observed drastic reduction in aRNA
production that occurs early on is not a plateau phase in
its strict sense, as we observed constant increases in
the yield, indicating the presence of residual productivity.
This observation is in contrast with a previous publication
showing a reduction in aRNA yield due to degradation
when incubations are extended for over 4h (30). We have
not noticed such RNA decay in our assays. Indeed, the
kinetics of the reaction did not plummet, even after the
recommended 6-h incubation.
Another point to consider when performing T7-IVT
ampliﬁcation for microarray sample preparation is the
ﬁnal output of the reaction. This ﬁnal output is of critical
importance since standard microarray sample preparation
requires a minimal 2mg of input material. This minimal
requirement is plentifully fulﬁlled when using the standard
6-h incubation, which generates yields in the range of 50–
60mg following a two-round reaction. To be implementa-
ble, the proposed restricted ampliﬁcation protocol must
also meet this minimal output requirement. In the present
study, the current output from the restricted ampliﬁcation
protocol, using the least abundant tissue (8-cell embryo)
was found to be suﬃcient for the preparation of two
microarray hybridization samples, proving it to be suit-
able for technical replications. Moreover, in spite of
this shorter ampliﬁcation duration, aRNA yields were
still higher than PCR-based ampliﬁcation outputs (such
as the SuperSMART), whose ﬁnal content in double-
stranded cDNA is in the range of 1–2mg (Clontech’s
user manual).
The use of a ﬂuorescent probe targeting a candidate
sequence to monitor the aRNA production in real
time provides the required mean to ensure that the ampli-
ﬁcation step performs following a true linear kinetic.
Furthermore, the use of the broken beacon may also pro-
vide a basis to study and better control the eﬃciency diver-
gences observed between platforms. These divergences
were shown to arise from the diﬀerent T7 promoter
sequences used to recruit the RNA polymerase (29).
In addition to highlighting the presence of an ampliﬁ-
cation distortion caused by homogenization of the yields,
we assessed its impact on microarray data interpretation.
In the case of scarce samples, such as early embryos or
micro-dissections, two ampliﬁcation rounds are inevitable;
we have thus not assessed the presence of a distortion
following the ﬁrst ampliﬁcation round. In fact, due to
insuﬃcient output following the ﬁrst restricted ampliﬁca-
tion, it was not possible to measure diﬀerences in the
output between both sample types. However, when mon-
itoring the aRNA production during the recommended
full 6-h incubations, both rounds showed ﬂattening kinet-
ics (Figures 3 and 6), suggesting an impact on relative
RNA abundance during both rounds. Nonetheless, we
cannot rule out that nonlinear kinetics could have a less
profound impact when performing only one ampliﬁcation
round. It was noticed that under the standard 6-h incuba-
tion protocol, the diﬀerence between sample types was
about 3.3-fold and 1.2-fold following the ﬁrst and
second rounds, respectively. By comparison, the diﬀerence
between the GV oocyte and the 8-cell samples was 4.5-fold
after two rounds of controlled ampliﬁcations. Given that
the restricted protocol was conﬁrmed to preserve the natu-
ral proportional diﬀerence between samples, this result
suggests that the distortion introduced during the second
ampliﬁcation round is more important. Further valida-
tions to assess the extent of the distortion introduced
during the ﬁrst round would be required for an in-depth
analysis of its impact.
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microarray data interpretation was assessed in the speciﬁc
physiological context of the early 8-cell bovine embryo,
which corresponds to the latest developmental stage of
the pre-EGA window. In 8-cell bovine embryo, total
RNA content represent residual maternal mRNA and as
expected, in the absence of transcriptional activity, which
characterizes this developmental window, nearly all of
the transcripts were found to be more abundant in the
GV oocyte than in the 8-cell embryo (Figure 7). The few
candidates found to be more abundant in the 8-cell
embryo (Figure 7B) could represent false positives or
genes involved in the early onset of embryonic genome
activation either through de novo RNA synthesis or
re-adenylation of maternal transcripts that were stored
in a de-adenylated state in the GV stage oocyte.
Maternal RNAs stored in the cytoplasm of the oocyte
have been shown to be stabilized partly by the removal
of their poly(A) tail and enclosed within ribonucleoprotein
complexes (31). The recruitment mechanisms by which
these dormant RNA are targeted for either translation
or decay are still largely uncharacterized. The current
model involves lengthening of the poly(A) tail, which
triggers binding of the poly(A)-binding protein, followed
by the formation of a loop bringing the 30 end in proxim-
ity to the 50 cap structure which facilitates binding of
translation initiation factors (32). It is thus generally
accepted that de-adenylated mRNAs are part of the
stored maternal RNA pools. During the initial step of
the T7-IVT procedure, reverse transcription of mRNA
using an oligo-dT bearing a T7 RNA polymerase pro-
moter sequence is selecting mRNA bearing long poly(A)
tail and could therefore explain the apparent preponder-
ance of some maternal transcripts in the 8-cell embryo
compared to the GV oocyte.
To validate the microarray data and further conﬁrm
the introduction of a relative skew by the standard
T7-IVT ampliﬁcation protocol, real-time PCR abundance
measurements of candidate gene transcripts were used as
a reference. This method showed an overall close concor-
dance between the restricted ampliﬁcation protocol and
the unampliﬁed reference (Figure 8). It also clearly high-
lighted that the recommended T7-IVT protocol systemat-
ically overrepresented the abundance of transcripts found
in the 8-cell embryo, thus conﬁrming the distortion in
the relative proportions of all ESTs across these two
developmental stages. Furthermore, when comparing can-
didate genes lists between the standard and restricted pro-
tocols, 116 candidates, or 10% (116/1175), of candidates
identiﬁed by the standard procedure appear to be false
positives. In addition to the distortion of relative RNA
abundance, these false positives could be the result of
the sequence driven bias introduced by extended incuba-
tions. Although these sequence driven biases have been
reported to be marginally frequent (5,7), it has been
recently reported that this sequence related skew can
aﬀect up to 16% of microarray reporters (6). Thus, the
overall loss of natural representation due to the T7-IVT
kinetics is about ﬁve times more important (603/1175)
than the combined false-positive rate. In other words, by
using the recommended procedure, more than half of the
truly diﬀerently abundant transcripts would not have been
detected. The candidates common to both techniques were
found to be those with the highest fold-change diﬀerence,
indicating that more subtle diﬀerences were lost with
aRNA output normalization.
CONCLUSION
Monitoring aRNA production in real time as provided a
novel perspective for the study of gene expression in situa-
tions where the natural RNA contents are divergent
between studied samples. Aside from situations involving
management of stored RNA pools such as the one pre-
sented herein, situations where the biological samples are
bearing diﬀerent RNA contents are most certainly preva-
lent in numerous physiological states through ﬂuctuation
in overall transcriptional activity. Within this context, the
use of housekeeping candidates for sample normalization
becomes problematic and the comparison of ﬁxed RNA
contents may provide irrelevant information. The compar-
ison of samples of known cell numbers oﬀers a novel dis-
covery potential for comparative gene expression. To take
advantage of this opportunity, the ampliﬁcation step must
preserve the initial proportional diﬀerence in RNA con-
tents. The loss in relative proportions across samples
during microarray sample preparation had not been con-
sidered nor assessed. We have shown here for the ﬁrst time
that ignoring the ampliﬁcation reaction kinetics signiﬁ-
cantly reduces the quality of microarray data. The result-
ing high incidence of undetected diﬀerences and skewed
proportions translate in a signiﬁcantly lower level of dis-
covery potential and may lead to irrelevant physiological
interpretation.
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